Skip to main content
Erschienen in: Diseases of the Colon & Rectum 2/2008

01.02.2008 | Original Contributions

Topical Sucralfate Decreases Pain After Hemorrhoidectomy and Improves Healing: A Randomized, Blinded, Controlled Study

verfasst von: P. J. Gupta, M.S., P. S. Heda, M.D., S. Kalaskar, B.H.M.S., V. P. Tamaskar, M.S.

Erschienen in: Diseases of the Colon & Rectum | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Oral and topical sucralfate is regularly used in ulcers of gastrointestinal tract, vaginal and perianal excoriations, and radiation burns. This study was designed to determine whether there was any advantage of topical application of sucralfate in reducing postoperative pain and promoting wound healing after open hemorrhoidectomy in patients with Grades III or IV hemorrhoids.

Methods

A total of 116 patients were randomly assigned to receive sucralfate cream (sucralfate group) or placebo cream (control group) applied to the surgical site. Weekly pain score was evaluated by using Visual Analog Scale. The amount of analgesic tablets consumed in each week also was assessed. At the end of four weeks, two independent surgeons assessed the wound healing.

Results

There was no significant difference in age, gender distribution, and number of excised hemorrhoid piles between the two groups. Patients in the topical sucralfate group experienced significantly less pain at Day 7 (Visual Analog Scale ± standard error of the mean, 3.7 ± 0.3 vs. 6.1 ± 0.7; P < 0.002) and at Day 14 (1.6 ± 0.2 vs. 3.1 ± 0.6; P < 0.01). Likewise patients who received sucralfate cream used less analgesic tablets compared with the placebo group. In the sucralfate group, the overall wound healing ranked significantly better than in controls (P < 0.02).

Conclusions

Topical sucralfate significantly reduces pain at Days 7 and 14 after hemorrhoidectomy and promotes faster wound healing compared with that of a placebo.
Literatur
1.
Zurück zum Zitat Davies J, Duffy D, Boyt N, Aghahoseini A, Alexander D, Leveson S. Botulinum toxin (botox) reduces pain after hemorrhoidectomy: results of a double-blind, randomized study. Dis Colon Rectum 2003;46:1097–102.PubMedCrossRef Davies J, Duffy D, Boyt N, Aghahoseini A, Alexander D, Leveson S. Botulinum toxin (botox) reduces pain after hemorrhoidectomy: results of a double-blind, randomized study. Dis Colon Rectum 2003;46:1097–102.PubMedCrossRef
2.
Zurück zum Zitat Al-Mulhim AS, Ali AM, Al-Masuod N, Alwahidi A. Posthemorrhoidectomy pain. A randomized controlled trial. Saudi Med J 2006;27:1538–41.PubMed Al-Mulhim AS, Ali AM, Al-Masuod N, Alwahidi A. Posthemorrhoidectomy pain. A randomized controlled trial. Saudi Med J 2006;27:1538–41.PubMed
3.
Zurück zum Zitat Pattana-Arun J, Sooriprasoet N, Sahakijrungruang C, Tantiphlachiva K, Rojanasakul A. Closed vs. ligasure hemorrhoidectomy: a prospective, randomized clinical trial. J Med Assoc Thai 2006;89:453–8.PubMed Pattana-Arun J, Sooriprasoet N, Sahakijrungruang C, Tantiphlachiva K, Rojanasakul A. Closed vs. ligasure hemorrhoidectomy: a prospective, randomized clinical trial. J Med Assoc Thai 2006;89:453–8.PubMed
4.
Zurück zum Zitat Chung CC, Cheung HY, Chan ES, Kwok SY, Li MK. Stapled hemorrhoidopexy vs. Harmonic scalpel hemorrhoidectomy: a randomized trial. Dis Colon Rectum 2005;48:1213–9.PubMedCrossRef Chung CC, Cheung HY, Chan ES, Kwok SY, Li MK. Stapled hemorrhoidopexy vs. Harmonic scalpel hemorrhoidectomy: a randomized trial. Dis Colon Rectum 2005;48:1213–9.PubMedCrossRef
5.
Zurück zum Zitat Cheetham MJ, Philips RK. Evidence-based practice in haemorrhoidectomy. Colorectal Dis 2001;3:126–34.PubMedCrossRef Cheetham MJ, Philips RK. Evidence-based practice in haemorrhoidectomy. Colorectal Dis 2001;3:126–34.PubMedCrossRef
6.
7.
Zurück zum Zitat Naslund I. Sucralfat ointment in treatment of perianal skin irritation. Dis Colon Rectum 1988;31:578–9.PubMedCrossRef Naslund I. Sucralfat ointment in treatment of perianal skin irritation. Dis Colon Rectum 1988;31:578–9.PubMedCrossRef
8.
Zurück zum Zitat Tryba M, Mantey-Stiers F. Antibacterial activity of sucralfate in human gastric juice. Am J Med 1987;83:125–7.PubMedCrossRef Tryba M, Mantey-Stiers F. Antibacterial activity of sucralfate in human gastric juice. Am J Med 1987;83:125–7.PubMedCrossRef
9.
Zurück zum Zitat Folkman J, Szabo S, Shing Y. Sucralfate affinity for fibroblast growth factor. J Cell Biol 1990;111:223a. Folkman J, Szabo S, Shing Y. Sucralfate affinity for fibroblast growth factor. J Cell Biol 1990;111:223a.
10.
Zurück zum Zitat Gul YA, Prasannan S, Jabar FM, Shaker AR, Moissinac K. Pharmacotherapy for chronic hemorrhagic radiation proctitis. World J Surg 2002;26:1499–502.PubMedCrossRef Gul YA, Prasannan S, Jabar FM, Shaker AR, Moissinac K. Pharmacotherapy for chronic hemorrhagic radiation proctitis. World J Surg 2002;26:1499–502.PubMedCrossRef
11.
Zurück zum Zitat Banati A, Chowdhury SR, Mazumder S. Topical use of sucralfate cream in second- and third-degree burns. Burns 2001;27:465–9.PubMedCrossRef Banati A, Chowdhury SR, Mazumder S. Topical use of sucralfate cream in second- and third-degree burns. Burns 2001;27:465–9.PubMedCrossRef
12.
Zurück zum Zitat Lyon CC, Stapleton M, Smith AJ, Griffiths CE, Beck MH. Topical sucralfate in the management of peristomal skin disease: an open study. Clin Exp Dermatol 2000;25:584–8.PubMedCrossRef Lyon CC, Stapleton M, Smith AJ, Griffiths CE, Beck MH. Topical sucralfate in the management of peristomal skin disease: an open study. Clin Exp Dermatol 2000;25:584–8.PubMedCrossRef
13.
Zurück zum Zitat Henriksson R, Franzen L, Edbom C, Littbrand B. Sucralfate: prophylaxis of mucosal damage during cancer therapy. Scand J Gastroenterol Suppl 1995;210:45–7.PubMedCrossRef Henriksson R, Franzen L, Edbom C, Littbrand B. Sucralfate: prophylaxis of mucosal damage during cancer therapy. Scand J Gastroenterol Suppl 1995;210:45–7.PubMedCrossRef
14.
Zurück zum Zitat Nicholson TJ, Armstrong D. Topical metronidazole (10 percent) decreases posthemorrhoidectomy pain and improves healing. Dis Colon Rectum 2004;47:711–6.PubMedCrossRef Nicholson TJ, Armstrong D. Topical metronidazole (10 percent) decreases posthemorrhoidectomy pain and improves healing. Dis Colon Rectum 2004;47:711–6.PubMedCrossRef
15.
Zurück zum Zitat La Torre F, Nicolai AP. Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled, clinical trial. Dis Colon Rectum 2004;47:704–10.PubMedCrossRef La Torre F, Nicolai AP. Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled, clinical trial. Dis Colon Rectum 2004;47:704–10.PubMedCrossRef
16.
Zurück zum Zitat Balfour L, Stojkovic SG, Botterill ID, Burke DA, Finan PJ, Sagar PM. A randomized, double-blind trial of the effect of metronidazole on pain after closed hemorrhoidectomy. Dis Colon Rectum 2002;45:1186–90.PubMedCrossRef Balfour L, Stojkovic SG, Botterill ID, Burke DA, Finan PJ, Sagar PM. A randomized, double-blind trial of the effect of metronidazole on pain after closed hemorrhoidectomy. Dis Colon Rectum 2002;45:1186–90.PubMedCrossRef
17.
Zurück zum Zitat Burch RM, McMillan BA. Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full-thickness skin wounds. Agents Actions 1991;34:229–31.PubMedCrossRef Burch RM, McMillan BA. Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full-thickness skin wounds. Agents Actions 1991;34:229–31.PubMedCrossRef
18.
Zurück zum Zitat Konturek SJ, Brzozowski T, Majka J, et al. Role of nitric oxide and prostaglandins in sucralfate-induced gastroprotection. Eur J Pharmacol 1992;211:277–9.PubMedCrossRef Konturek SJ, Brzozowski T, Majka J, et al. Role of nitric oxide and prostaglandins in sucralfate-induced gastroprotection. Eur J Pharmacol 1992;211:277–9.PubMedCrossRef
19.
Zurück zum Zitat Tytgat GN. Future clinical development of sucralfate. In: Hollander D, Tytgat GN, eds. Sucralfate: from basic science to the bedside. New York: Springer, 1995:339–49. Tytgat GN. Future clinical development of sucralfate. In: Hollander D, Tytgat GN, eds. Sucralfate: from basic science to the bedside. New York: Springer, 1995:339–49.
Metadaten
Titel
Topical Sucralfate Decreases Pain After Hemorrhoidectomy and Improves Healing: A Randomized, Blinded, Controlled Study
verfasst von
P. J. Gupta, M.S.
P. S. Heda, M.D.
S. Kalaskar, B.H.M.S.
V. P. Tamaskar, M.S.
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Diseases of the Colon & Rectum / Ausgabe 2/2008
Print ISSN: 0012-3706
Elektronische ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-007-9092-4

Weitere Artikel der Ausgabe 2/2008

Diseases of the Colon & Rectum 2/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.